20 July 2020, 7pm* - 8.30pm SGT
Via Zoom
*Corresponds to 7am Eastern Standard Time (EST), 1pm Central European Time (CET) & 9pm Australian Central Standard Time (ACT)
The incidence of Drug-Induced Liver Injury (DILI) is a growing challenge because of the ever-increasing number of drugs used in medical care. This webinar brings together leading DILI experts from regulatory authorities, the pharmaceutical industry and academia as they introduce the consensus report of the Council for International Organizations of Medical Sciences (CIOMS) DILI Working Group. The report provides a critical framework and essential tools to detect, diagnose and manage DILI during drug development and post-marketing.
The webinar welcomes professionals from the pharmaceutical industry, including investigators who capture, analyze and communicate liver safety data in drug development, regulators who evaluate new products and/or emerging DILI biomarkers, and health care providers who monitor and manage patients treated with potentially hepatotoxic drugs.
CoRE is a registered provider of Continuing Professional Education (CPE) with the Singapore Pharmacy Council (SPC) and Continuing Medical Education (CME) with the Singapore Medical Council (SMC). CPE and CME credits are available for eligible CoRE events, subject to approval by the respective Councils. Attendees seeking credits should provide their CPE or CME number when registering their attendance at the event. Should the event be conducted online, please provide your CPE/CME number in the respective e-registration form. Attendance details will be submitted to the relevant Council following the event, with credits awarded upon approval.
Click
here to read the report.
Date and Time
20 Jul 2020 @ 19:00 - 20 Jul 2020 @ 20:30
Speaker
MODERATOR
Prof Mark I Avigan
Associate Director
Critical Path Initiatives
Office of Pharmacovigilance & Epidemiology
Center for Drug Evaluation & Research
U.S. Food and Drug Administration
SPEAKERS AND PANELLISTS
Prof Hervé Le Louet
President
Council for International Organizations of
Medical Sciences (CIOMS)
Head, Vigilance department
Hôpital Universitaire Henri Mondor AP-HP
Paris Créteil, France
Dr Arie Regev
Chair
Liver and GI Safety Committee
Chair
Safety Advisory Hub
Global Patient Safety
Eli Lilly and Company
Dr Walter Straus
Associate Vice-President and Chair
Organ-Specific Safety Boards
Merck Research Laboratories
MSD
The United States of America
Prof Raúl J Andrade
Head
Department of Medicine
University of Málaga
Chief
Gastroenterology Service
Virgen de la Victoria University Hospital
Málaga (Spain)
Prof Einar Stefán Björnsson
Chief
Internal Medicine
Landspitali University Hospital
Reykjavik (Iceland)